In silico antibody accessibility analysis indicates that ectodomain epitopes are transiently exposed, while MPER epitopes are virtually always occluded in the pre-fusion trimer.
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...
Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which ...
News-Medical.Net on MSN
To knock down health-system hurdles between you and HIV prevention, try these 6 things
That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...
The Punch on MSN
How cycle of strikes left public hospitals helpless in 2025
Explore Nigeria's health crisis of 2025, a year marked by crippling strikes, major funding cuts, and disease outbreaks that left public hospitals helpless.
The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
NEWS10 ABC on MSN
Crews battle fire, roof collapse at Troy Unity House building
According to Troy Fire Department Chief Rich Cellucci, the fire initially came in as a fire alarm alert. Upon arrival, crews ...
The United States will provide up to $1.6 billion while Kenya pledges $850 million in domestic health spending.
Up to additional $20M in milestone and other future payments Future Pak becomes exclusive U.S. marketer for Mytesi and Canalevia-CA1 Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results